Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-15
2005-03-15
Woitach, Joe (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
06867196
ABSTRACT:
A process for delivering a nucleic acid to a cardiac tissue cell in a mammal is described, comprising introducing a composition consisting of a nucleic acid to a blood vessel, which subsequently delivers the nucleic acid to the cardiac tissue cell. The nucleic acid can be DNA or RNA or plasmid DNA or viral. This process is for purposes of gene therapy, and research.
REFERENCES:
patent: 5674192 (1997-10-01), Sahatjian et al.
patent: 5693622 (1997-12-01), Wolff et al.
patent: 5698531 (1997-12-01), Nabel et al.
patent: 5792453 (1998-08-01), Hammond et al.
patent: 5830879 (1998-11-01), Isner
patent: 5922687 (1999-07-01), Man et al.
patent: 6627616 (2003-09-01), Monahan et al.
Hajjar, R.J. et al. Proc. Natl. Acad. Sci. USA 95;5251-5256, Apr. 1998.*
Leclerc, G et al. J. Clin. Invest. 90:936-944, Sep. 1992.*
Anderson, W.F. Nature 93:25-30, Apr. 1998.*
Verma, I. M. et al. Nature 389:239-242, Sep. 1997.*
Morishita, R. et al. J. Clin. Invest. 91:2580-2585, Jun. 1993.*
Merriam-Webster's Medical Desk Dictionary; Merriam-Webster Inc., Springfield, MA, 1993.*
Acsadi, G. et al., “Direct Gene Transfer and Expression Into Rat Heart In Vivo.”The New BiologistJan. 1991; vol. 3, No. 1; 71-81.
Barr, E. et al., “Efficient Catheter-Mediated Gene Transfer Into the Heart Using Replication-Defective Adenovirus.”Gene Therapy1994; 1; 51-58.
Lin, H. et al., “Expression of Recombinant Genes in Myocardium In Vivo After Direct Injection of DNA.”CirculationDec. 1990; vol. 82, No. 6; 2217-2221.
Losordo, D. et al., “Gene Therapy for Myocardial Angiogenesis.”Circulation1998; 98; 2800-2804.
Mack, C. et al., “Salvage Angiogenesis Induced by Adenovirus-Mediated Gene Transfer of Vascular Endothelial Growth Factor Protects Against Ischemic Vascular Occlusion.”Journal of Vascular SurgeryApr. 1998; vol. 27. No. 4; 1-12.
Donahue, JK. et al., “Acceleration of Widespread Adenoviral Gene Transfer to Intact Rabbit Hearts by Coronary Perfusion With Low Calcium and Serotonin.”Gene Therapy1998; vol. 5; 630-634.
Gal, Dov et al., “Direct Myocardial Transfection In Two Animal Models,”Laboratory Investigation1993; vol. 68, No. 1; p. 18.
Hajjar, Roger J. et al., “Modulation of Ventricular Function Through Gene Transfer In Vivo,”Proc. Natl. Acad. Sci. USAApr. 1998; vol. 95, pp. 5251-5256.
Budker Vladimir G.
Hagstrom James E.
Herweijer Hans
Monahan Sean D.
Rozema David B.
Johnson Mark K.
Mirus Bio Corporation
Woitach Joe
LandOfFree
Process for delivering nucleic acids to cardiac tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for delivering nucleic acids to cardiac tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for delivering nucleic acids to cardiac tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3443792